首页> 外文期刊>Bulletin of experimental biology and medicine >Study of Photoinduced Antitumor Activity of Phthalocyanin-Based Nanostructures as Pro-Photosensitizers in Photodynamic Therapy of Malignant Tumors In Vivo
【24h】

Study of Photoinduced Antitumor Activity of Phthalocyanin-Based Nanostructures as Pro-Photosensitizers in Photodynamic Therapy of Malignant Tumors In Vivo

机译:酞菁基纳米结构作为前光敏剂的光诱导抗肿瘤活性在体内恶性肿瘤光动力治疗中的研究

获取原文
获取原文并翻译 | 示例
           

摘要

Nanoparticles of aluminum and zinc phthalocyanin and metal-free phthalocyanin (AlPc, ZnPc, and H2Pc), whose molecular forms are photosensitizers, can serve as effective "prophotosensitizers" in photodynamic therapy for malignant tumors. Transition (stimulation) of photo-inert nanoparticles into a photoactive photosensitizer is realized locally in the tumor node by its exposure to potent laser pulses. Systemic injection of AlPc, ZnPc, and H2Pc nanoparticles has not led to accumulation of their photoactive form in the skin, which can lead to the development of skin phototoxicity. Effective protocols of photodynamic therapy with ZnPc nanoparticles are determined. The use of these protocols in mice with S-37 sarcoma led to 92-70% tumor growth inhibition, 48% improvement of survival, and cure in 84% cases.
机译:铝和锌酞菁和无金属酞菁(AlPc,ZnPc和H2Pc)的纳米颗粒,其分子形式为光敏剂,可在恶性肿瘤的光动力治疗中用作有效的“前光敏剂”。光惰性纳米粒子向光敏光敏剂的转变(刺激)是通过将其暴露于强激光脉冲而在肿瘤节点中局部实现的。全身注射AlPc,ZnPc和H2Pc纳米粒子并没有导致其光敏形式在皮肤中积累,而这可能导致皮肤光毒性的发展。确定了用ZnPc纳米粒子进行光动力治疗的有效方案。在具有S-37肉瘤的小鼠中使用这些方案可导致92-70%的肿瘤生长抑制,48%的存活率改善和84%的病例治愈。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号